SANKYO C22 (Benicar HCT 12.5 mg / 20 mg)
Generic Name: hydrochlorothiazide/olmesartan
Pill imprint SANKYO C22 has been identified as Benicar HCT 12.5 mg / 20 mg.
Benicar HCT is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Benicar HCT 12.5 mg / 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for SANKYO C22 (Benicar HCT 12.5 mg / 20 mg)
- Generic Name:
- 12.5 mg / 20 mg
- 9.00 mm
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Sankyo Pharma
- National Drug Code (NDC):
- Inactive Ingredients:
- hydroxypropyl cellulose
low substituted hydroxypropyl cellulose
ferric oxide red
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|54868-5170||Physicians Total Care Inc (repackager)|
|35356-0256||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about Benicar HCT (hydrochlorothiazide / olmesartan)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...